drugset / Press release
Emergent BioSolutions Initiates NIAID-Funded Phase 1b Clinical Study to Evaluate Broad-Spectrum Antiviral UV-4B for Dengue
2017-02-01 · Emergent BioSolutions · original emergentbiosolutions.com ↗
020117 - EBS Initiates Phase 1b for UV-4B Dengue Treatment FINAL.pdf 71.9 KB
The release as fetched from its publisher. emergentbiosolutions.com ↗